Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-013365
Filing Date
2024-05-16
Accepted
2024-05-16 16:55:09
Documents
2
Period of Report
2024-05-10

Document Format Files

Seq Description Document Type Size
1 form3-05162024_080503.html 3  
1 form3-05162024_080503.xml 3 1807
2 ex24-05162024_080506.htm EX-24 8884
  Complete submission text file 0001415889-24-013365.txt   12133
Mailing Address 733 CONCORD AVENUE C/O WAVE LIFE SCIENCES USA, INC. CAMBRIDGE MA 02138
Business Address
Gaiero David G (Reporting) CIK: 0001799784 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39980 | Film No.: 24956441

Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)